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SPECIAL ARTICLE
Abstract
Introduction: Cardiac arrest during heart surgery is a com-
mon procedure and allows the surgeon to perform surgical pro-
cedures in an environment free of blood and movement. Using 
a model of isolated rat heart, the authors compare a new car-
dioplegic solution containing histidine-tryptophan-glutamate 
(group 2) with the histidine-tryptophan-alphacetoglutarate 
(group 1) routinely used by some cardiac surgeons. 
Objective: To assess caspase, IL-8 and KI-67 in isolated rat 
hearts using immunohistochemistry. 
Methods: 20 Wistar male rats were anesthetized and 
heparinized. The chest was opened, cardioctomy was performed 
and 40 ml/kg of the appropriate cardioplegic solution was 
infused. The hearts were kept for 2 hours at 4°C in the same 
solution, and thereafter, placed in the Langendorff apparatus for 
30 minutes with Ringer-Locke solution. Immunohistochemistry 
analysis of caspase, IL-8, and KI-67 were performed. 
Results: The concentration of caspase was lower in group 2 and 
Ki-67 was higher in group 2, both P<0.05. There was no statistical 
difference between the values of IL-8 between the groups. 
Conclusion: Histidine-tryptophan-glutamate solution was 
better than histidine-tryptophan-alphacetoglutarate solution 
because it reduced caspase (apoptosis), increased KI-67 (cell 
proliferation), and showed no difference in IL-8 levels compared 
to group 1. This suggests that the histidine-tryptophan-glutamate 
solution was more efficient than the histidine-tryptophan-
alphacetoglutarate for the preservation of hearts of rat 
cardiomyocytes.
Descriptors: Heart Arrest, Induced. Myocardial Ischemia. Heart.
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to myocyte: the decrease in lactate and raising the pH in the 
mitochondrial matrix, even in ischaemia, avoiding intracellu-
lar acidosis and edema, and contributing to the maintenance 
of intracellular adenosine triphosphate (ATP), protecting the 
myocyte of ischemia - reperfusion lesion.
In turn, the reduction of reperfusion injury cause decrease 
of caspase [10-12] and IL- 8, due to the reduction in cellular 
apoptosis and necrosis, respectively [13,14]. Nevertheless, 
the reduction of reperfusion injury may not be acting alone 
on behalf myocyte. Proliferative proteins such as KI- 67, 
could be re-coded, thus contributing to the reduction of the 
cell death and formation of new myocardial fibers [15,16]. 
This study assess HTG solution as a cardioplegic agent in 
isolated rat heart, considering immunohistochemical analysis 
of caspase markers, IL-8 and KI-67.
METHODS
After approval by the Ethics Committee on Animal Ex-
perimentation of the Faculty of Medicine of São José do Rio 
Preto (autorization number 015/2012), 20 male Wistar rats 
(10 in each group) were used, weighing 280±29 grams.
All animals received care according to the recommenda-
tions of the Committee on Care and Use of Laboratory An-
INTRODUCTION
Induction of temporary arrest of the heart during cardiac 
surgery is a relatively common procedure that allows the sur-
geon to perform procedures in an environment free of blood 
and movement [1-3]. One of the cardioplegic agents is histi-
dine-tryptophan-ketoglutarate (HTK) solution.
The HTK was tested by Bretschneider et al. [ 4] in Ger-
many, 1975. Its mechanism of action comes from the absence 
of calcium, which prevents its influx into the cell by type “L” 
calcium channel in the plateau phase of the potential action, 
inhibiting the release of calcium from the sarcoplasmic retic-
ulum over the myocyte, resulting in inactivation of myofila-
ments [5,6].
This mechanism is complemented by cellular protection 
given by the constituents of this solution, whose main func-
tions include: 1 - histidine: temperature-dependent buffer 
system, inhibitor of matrix metalloproteinases and cell im-
permeant [7] 2 – tryptophan: acts in maintaining the integrity 
of cell membrane [8], and 3 - ketoglutarate: improves max-
imum developed pressure and prevents increased creatine 
kinase MB fraction [8].
According Pisarenko et al. [9], the substitution of al-
pha-Ketoglutaric acid by glutamate bring some advantages 
Abbreviations, acronyms and symbols
ATP Adenosine triphosphate 
BSA bovine serum albumin
MOD mean optical density 
HTG histidine-tryptophan-glutamate 
HTK histidine-tryptophan-ketoglutarate 
IL Interleukin 
IP Intraperitoneal 
AU Arbitrary units
Resumo
Introdução: A parada do coração durante a cirurgia 
cardíaca é procedimento comum e permite que o cirurgião 
realize os procedimentos cirúrgicos em ambiente isento de 
sangue e movimento. Os autores comparam, em modelo de 
coração isolado de rato, uma nova solução cardioplégica com 
histidina-triptofano-glutamato (grupo 2) com a histidina-
triptofano-alfacetoglutarato (grupo 1) já utilizada de rotina por 
alguns cirurgiões cardíacos. 
Objetivo: Avaliar por análise imuno-histoquímica a caspase, 
a IL-8 e KI-67 em corações isolados de ratos. 
Métodos: 20 ratos machos de raça Wistar foram anestesiados 
e heparinizados. O tórax foi aberto, realizado cardiectomia e 
infundido 40 ml/kg de solução cardioplégica apropriada. Os 
corações foram mantidos por 2 horas na mesma solução a 4oC 
e, após esse período, colocados em aparato de Langendorff por 
30 minutos com solução de Ringer Locke. Foram feitas análises 
imuno-histoquímicas para caspase, IL-8 e KI-67. 
Resultados: A concentração de caspase estava menor no 
grupo 2 e da KI-67 estava mais elevada no grupo 2, ambos com 
P<0,05. Não houve diferença estatística entre os valores de IL-8 
entre os grupos. 
Conclusão: A solução com histidina-triptofano-glutamato 
foi melhor que a com histidina-triptofano-cetoglutarato, pois 
reduziu a caspase (apoptose), aumentou o KI-67 (proliferação 
celular) e não apresentou valores diferentes de IL-8 (inflamação 
e necrose) que no grupo 1. Isso sugere que a solução histidina-
triptofano-glutamato foi mais eficiente que a histidina-
triptofano-cetoglutarato na preservação dos cardiomiócitos dos 
corações de ratos.
Descritores: Parada Cardíaca Induzida. Isquemia Miocárdica. 
Coração.
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imals - Institute of Laboratory Animal Resources (ILAR) - 
National Research Council, United States [17].
Experimental Protocol
The animals were anesthetized with an injection of 65 
mg/kg intraperitoneal sodium pentobarbital and received IP 
systemic heparin (500 IU/kg). After opening the chest, car-
diectomy was performed . Hearts received Ringer’s lactate 
solution to “wash” the coronary tree and then cardioplegic 
solution according to the corresponding group.
The hearts in this phase of the experiment were divided 
into 2 groups. In group 1, was used HTK solution at 4°C 
and in Group 2, solution of histidine-tryptophan-glutamate 
(HTG) at 4°C. Table 1 shows the composition of each solu-
tion. In all cases, the infusion of cardioplegia was performed 
as a single dose 40 ml/kg at the aortic root, followed by im-
mersion of the organ in the same solution for 2 hours at 4°C.
After this time, the hearts were placed in a Langendorff 
system and perfused with oxygenated Locke Ringer buffer 
under normothermy and constant pressure of 100 cm H2O 
for gravitational method for 30 minutes. The drainage of the 
right ventricle was performed by opening the pulmonary ar-
tery, and the right atrium was maintained intact in order to 
preserve the sinus node [18].
Three threads of epicardial pacemaker were inserted at 
equidistant points of the ventricles for electrocardiographic 
documentation of cardiac events. The time of onset of ven-
tricular fibrillation and the first heartbeat counted from the 
start of infusion of Ringer Locke solution was noted.
After 30 minutes of infusion of Ringer Locke, the ex-
periment was discontinued. The hearts were removed from 
the Langendorff system and fragments of the cardiac apex, 
which were stored in sterile Falcon type tubes containing 
10% formalin for subsequent histological and immunohisto-
chemical preparation.
Histological and immunohistochemical technique 
preparation
Initially, the material was embedded in paraffin, a proce-
dure that provides resistance allow for cutting thickness of 3m 
and placed on silanized slides. The silanization of the blades 
consisted in preparing these with an adhesive that fixes the 
fragment to the blades, preventing their detachment during 
the immunohistochemical procedure. For this, they were im-
mersed in acetone P.a. (2 minutes), 4% silane solution diluted 
with acetone (2 minutes) and again in acetone P.a. (4 to 5 dips). 
The drying of the slides was performed in an oven at 60ºC.
The block was attached to the microtome, the slice thick-
ness was set to 3 µm and the cuts placed on silanized identi-
fied and left in an oven at 60°C for 24 hours. The blade went 
through the process of deparaffinization in xylene, followed 
by hydration in absolute alcohol I, II and III, finishing with 
six dives in tap water, incubated with 3% hydrogen peroxide 
for 30 minutes to block endogenous peroxidase.
Antigen retrieval was performed in the steamer with spe-
cific buffer for each antibody for 30 minutes (Table 2). Then 
the slides were covered up with a solution containing fetal bo-
vine serum (BSA) and incubated with the primary antibody.
Table 1. Composition of solutions used.
Substance
Sodium chloride
Potassium chloride
Magnesium chloride
Calcium chloride
Potassium-hydrogen-2-ketoglutarate
Glutamate
Histidine
Histidine chloride, H2O
Tryptophan
Mannitol
Water for injection
HTK (g/L)
0.8766
0.671
0.8132
0.0022
0.1842
---
27.9289
3.7733
0.4085
5.4651
a 1000 ml
HTG (g/L)
0.8766
0.671
0.8132
0.0022
---
0.1842
27.9289
3.7733
0.4085
5.4651
a 1000 ml
HTK: Histidine-tryptophan ketoglutarate; HTG: histidine-
tryptophan-glutamate
Table 2. List of antibodies used.
Antibody
anti-Ki-67
anti-Caspase 3
anti-IL-8
Specificity
Monoclonal
Polyclonal
Monoclonal
Dilution
1:200
1:1000
1:50
Buffer
Citrato pH6
Citrato pH6
Citrato pH6
Lab
Biocare Medical
Abcam
Santa Cruz
After this step, the slides were washed in PBS solution 
and incubated for 15 minutes with Starr Trek Universal HRP 
Detection kit (Biocare Medical®), which consisted in second-
ary antibody biotinylated for 1 hour and streptavidin-peroxi-
dase complex for 30 minutes, followed by washing with PBS 
for 15 minutes. The revelation was performed with substrate 
chromogen (DAB Betazoidchromogen) of the Starr Trek 
Universal HRP Detection kit (Biocare Medical®) for 2 to 5 
minutes, and counterstained with Harrys hematoxylin for 40 
seconds. The tissues were dehydrated in alcohol in ascending 
degree and bathed in xylene before mounting the slides on 
ERV-MOUNT amid (Erviegas®).
Negative control reactions were obtained by omitting the 
primary antibody. Tonsil tissue was used for Ki-67 reactions and 
Caspase 3 and as positive control breast tissue for IL-8 reaction.
Quantification of immunohistochemical staining
Slides were photographed and quantified by enzyme Ax-
ioVision software on X40 magnification microscope Zeiss 
Axioskop 2. For each sample, three regions of cardiac tissue 
and 20 points of myocardial cell were marked in each region 
were selected. Thus, 60 different points on each sample were 
assessed by obtaining the average relative intensity of im-
munoreactivity. The values were obtained in arbitrary units 
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(AU). The average optical density (AOD) was obtained with 
the aid of the following formula:
AOD = 255 – AU
This formula showed the intensity of immunostaining 
specifically in immunoreactive areas.
Statistical Analysis
The data were subjected to the Kolmogorov-Smirnov test 
and subsequently the parametric analysis by unpaired Stu-
dent’s t test or non-parametric by Mann-Whitney test when 
appropriate, and Fisher’s exact test for categorical data. Re-
sults were expressed only in mean ± standard deviation due 
to the fact all variables behave as continuous quantitative 
with Gaussian distribution. P values were presented, and 
those who were less than 0.05 were considered significant. 
The GraphPad Instat and Prism 6.0 softwares of statistical 
analysis, both for Windows® were used.
RESULTS
The average weight of the animals was 277.4 ± 24.6 g 
(group 1) and 288 ± 34.5 g (group 2 ), respectively, with no 
significant difference between groups (P=0.4396). Regarding 
the average volume of Ringer Locke collected from coronary 
sinus after 30 minutes (363.1 ± 177.3 ml and 277.4 ± 33.7 
ml, respectively), there was no significant difference between 
groups (P=0.1923).
Findings during perfusion with cardioplegic solution 
and Ringer Locke
All hearts showed adequate perfusion of cardioplegia 
and Ringer Locke, evidenced by clear staining in the ven-
tricular wall. The average heart rate after 5 minutes of perfu-
sion (233±36 and 188±53.4 beats per minute, respectively), 
showed a significant difference (P=0.0086). The time of on-
set of ventricular fibrillation (49 ± 28.2 and 45 ± 17 seconds, 
respectively) and time to first heartbeat (153 ± 78 and 117 ± 
96.8 seconds respectively) showed no significant difference 
(P=0.5869 and P=0.187, respectively).
Immunohistochemical findings
After 2 hours of ischemia and 30 minutes of reperfu-
sion, caspase activity was significantly lower in group 2 
(P<0.0001), the activity of KI-67 was higher in group 2 
(P<0.0001) and IL-8 was not different between groups 
(Figure 1).
DISCUSSION
Myocardial ischemia causes various cardiac effects, 
such as decreases force of contraction; increases diastolic 
pressure, indicating contraction of myofibrils in isovolumic 
conditions, causes a decline in phosphocreatine and ATP; de-
Fig. 1 - Histograms showing mean optical densities of: (A) caspase, (B) KI-
67 and (C) IL-8. Group 1: solution with histidine-tryptophan-ketoglutarate, 
Group 2: solution with histidine-tryptophan-glutamate
creases contraction, and glutamate and aspartate; increases 
lactate, pyruvate, alanine and succinate [9]. According Pis-
arenko et al. [9] the addition of glutamate in the perfusate 
keeps the intracellular ATP and decreases both lactate and 
pyruvate as that contribute to acidosis. These effects contrib-
ute to improve cardiac function recovery after ischemia. Our 
results show similar behavior in the two solutions studied 
concerning the time and duration of ventricular fibrillation 
first beat, however, it was better for group 2 concerning heart 
rate, which was lower, which can be correlated with lower 
acidosis, probably myocyte .
Another process that is intrinsically related to isch-
emia-reperfusion injury is apoptosis [10,11], characterized 
by morphological changes such as chromatin condensation, 
fragmentation of nuclei and formation of “apoptotic bod-
ies”. These changes are made by a family of proteases called 
caspases [12]. The degree of caspase activation is directly re-
lated to the degree of apoptosis, which plays a critical factor 
in the recovery of cardiac function [13].
Our results demonstrate less caspase activity in group 2, 
suggesting a potential protective for myocardial function.
In contrast to apoptosis, necrosis is an irreversible pro-
cess of cell death due to the breakdown in cellular homeo-
stasis. There is disruption of the cell membrane, with leakage 
from the cytosol to the extracellular medium, leukocyte mar-
gination and activation of the inflammatory cascade [13,14]. 
Anselmi et al. [14] have described IL-8 peak at 35 minutes of 
reperfusion and IL-6 in 75 minutes. Lee et al. [13] stated that 
the HTK solution inhibits increase of interleukin. Thus, as in 
this study there was no significant difference in IL-8 between 
groups 1 and 2, and we can infer that the anti-inflammatory 
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88
Rev Bras Cir Cardiovasc | Braz J Cardiovasc Surg
Rev Bras Cir Cardiovasc 2014;29(1):83-8Oliveira MAB, et al. - Comparison of the solution of histidine-tryptophan-
alfacetoglutarate with histidine-tryptophan-glutamate as cardioplegic agents 
in isolated rat hearts: an immunohistochemical study
14. Anselmi A, Abbate A, Girola F, Nasso G, Biondi-Zoccai GG, 
Possati G, et al. Myocardial ischemia, stunning, inflammation, 
and apoptosis during cardiac surgery: a review of evidence. Eur 
J Cardiothorac Surg. 2004;25(3):304-11.
15. Lee Y. To proliferate or not to proliferate. Cardiovasc Res. 
2010;86(3):347-8.
16. Walsh S, Pontén A, Fleischmann BK, Jovinge S. Cardiomyocyte 
cell cycle control and growth estimation in vivo: an analysis based 
on cardiomyocyte nuclei. Cardiovasc Res. 2010;86(3):365-73.
17. Committee on Care and Use of Laboratory Animals - Institute of 
Laboratory Animal Resources - Commission on Life Sciences - 
National Research Council. Guide for the care and use of laboratory 
animals. 8th ed. Washington: National Academies Press; 2010. 211p.
18. Lahaye Sle D, Gratas-Delamarche A, Malardé L, Vincent S, Zguira 
MS, Morel SL, et al. Intense exercise training induces adaptation 
in expression and responsiveness of cardiac β-adrenoceptors in 
diabetic rats. Cardiovasc Diabetol. 2010;9:72.
19. Kusumi T, Minakawa M, Fukui K, Saito S, Ohashi M, Sato F, et 
al. Cardiac tumor comprising two components including typical 
myxoma and atypical hypercellularity suggesting a malignant 
change. Cardiovasc Pathol. 2009;18(6):369-74.
20. Suvarna SK, Royds JA. The nature of the cardiac myxoma. Int J 
Cardiol. 1996;57(3):211-6.
21. Brunner-La Rocca HP, Vogt PR, Burke AP, Schneider J, Jenni R, 
Turina MI. A primary cardiac sarcoma with unusual histology and 
clinical course. Ann Thorac Surg. 2001;71(5):1675-7.
